Sign In
Buy BIOA
$16.04
-0.500 (-3.02%)
At Close: Jun 03, 2026
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ:BIOA) pursuant and/or traceable to
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit – BIOA
01:14pm, Monday, 27'th Jan 2025
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA) of a class action securities lawsuit.
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BIOA
11:15am, Monday, 27'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against BioAge Labs, Inc.
10:45am, Monday, 27'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc.
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its s
Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIOA
08:30am, Monday, 27'th Jan 2025
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securi
SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege th
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities
BIOA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of BioAge Labs, Inc. to Contact the Firm Today!
07:00am, Monday, 27'th Jan 2025
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bio
Shareholders that lost money on BioAge Labs, Inc.(BIOA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
05:45am, Monday, 27'th Jan 2025
NEW YORK , Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class
NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities
NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities
